Reaktion #49005

ord-1e69dbeb3ebd476eb9a8c6c12fb5304e

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Temperaturwith cooling the reaction vessel in an ice-bath under a nitrogen atmosphere
  2. 2
    SonstigeThe ice-bath was removed
  3. 3
    SonstigeAfter completion of the reaction
  4. 4
    Extraktionthe reaction mixture was extracted with ethyl acetate
  5. 5
    Waschenthe organic layer was washed sequentially with water and saturated brine
  6. 6
    Trocknendried over anhydrous Na2SO4
  7. 7
    Einengenconcentrated under reduced pressure
  8. 8
    SonstigeThe resultant yellow residue was purified by silica gel column chromatography (Mega Bond Elut, Varian, 5% methanol/methylene chloride as an eluent)
  9. 9
    EinengenThe resultant fraction was concentrated under reduced pressure
  10. 10
    Sonstigethe oily residue was triturated with 5% ethyl acetate/hexane

Vorschrift

Namely, (E)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5-[(2-methylsulfanyl-ethyoxyimino)-methyl]-benzamide (104.8 mg, 0.184 mmol) was dissolved in methylene chloride (anhydrous, 10 mL). Borane-pyridine complex (140 μL, 1.38 mmol) and then dichloroacetic acid (115 μL, 1.38 mmol) were added thereto with cooling the reaction vessel in an ice-bath under a nitrogen atmosphere. The ice-bath was removed, and the mixture was stirred at room temperature for 17 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, and the organic layer was washed sequentially with water and saturated brine, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The resultant yellow residue was purified by silica gel column chromatography (Mega Bond Elut, Varian, 5% methanol/methylene chloride as an eluent). The resultant fraction was concentrated under reduced pressure and the oily residue was triturated with 5% ethyl acetate/hexane to give 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5-[(2-methylsulfanyl-ethoxyamino)-methyl]-benzamide (110 mg) as a white solid.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07745663B2uspto-grants-2010_06